Viewing Study NCT05506969

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:48 PM

Ignite Modification Date: 2026-02-20 @ 11:49 PM

Study NCT ID: NCT05506969

Status: COMPLETED

Last Update Posted: 2025-07-29

First Post: 2022-08-10

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age

Sponsor: Dynavax Technologies Corporation

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module